Association Between Preexisting ILAs, Smoking History and ICI-Related Pneumonitis
Researchers investigated the association between preexisting interstitial lung abnormalities and immune checkpoint inhibitor-related pneumonitis.
Diagnosis & Disease Information
High-Risk Melanoma Patients More Likely to Receive Immunotherapy at End of Life
Metastatic melanoma patients at the highest risk of death are more likely than lower-risk patients to receive immunotherapy near the end of their life.
Lorazepam Use Linked to Shorter PFS, OS in Several Cancers
Lorazepam use may impact progression-free survival and overall survival in patients with a range of cancers, new research suggests.
Higher Cardiorespiratory Fitness May Protect Men From Certain Cancers
Higher cardiorespiratory fitness may protect men from lung, head and neck, gastrointestinal, and genitourinary cancers.
T-VEC Demonstrates Long-Term Efficacy in High-Risk Melanoma
Patients with advanced melanoma who receive T-VEC prior to surgery have better long-term outcomes than patients treated with surgery alone, updated data suggest.
Hepzato Kit Approved for Unresectable Hepatic-Dominant Metastatic Uveal Melanoma
The Hepzato Kit (melphalan/hepatic delivery system) is approved as a liver-directed treatment for adults with metastatic uveal melanoma and unresectable hepatic metastases.
Melanoma Presentation, Mortality Varies by Race
Black patients face higher mortality with melanoma independent of insurance status and severity at diagnosis.
Follow-Up Study Confirms Safety, Efficacy of Neoadjuvant Immunotherapy in Resectable Cutaneous Melanoma
A follow-up study to a phase 1b clinical trial demonstrated the efficacy of neoadjuvant therapy in patients with stage III/IV cutaneous melanoma at 5-year follow-up.
CLL Treatment Affects ICI Efficacy in Patients With Melanoma and CLL
Treating advanced melanoma with immune checkpoint inhibitors can be safe and effective in patients with concomitant CLL, a study suggests.
Preop Stereotactic Radiosurgery May Aid Outcomes With Resected Brain Metastases
Several tumor and treatment factors were tied to risk for poorer outcomes.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...